Source link : https://www.newshealth.biz/health-news/combining-semaglutide-and-mineralocorticoids-may-improve-ckd/
MADRID — The benefits of semaglutide treatment in reducing kidney disease, cardiovascular, and mortality risks in people with type 2 diabetes and chronic kidney disease (CKD) are observed regardless of whether patients are also being treated with mineralocorticoid receptor antagonists (MRAs), a subanalysis of the FLOW trial showed. “Given the [separate] benefits of MRA, and […]
Author : News Health
Publish date : 2024-09-19 10:11:20
Copyright for syndicated content belongs to the linked Source.
Categories